These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24261981)

  • 1. Production of recombinant therapeutic proteins in human cells: current achievements and future perspectives.
    Picanco-Castro V; Biaggio RT; Cova DT; Swiech K
    Protein Pept Lett; 2013 Dec; 20(12):1373-81. PubMed ID: 24261981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cells: new platform for recombinant therapeutic protein production.
    Swiech K; Picanço-Castro V; Covas DT
    Protein Expr Purif; 2012 Jul; 84(1):147-53. PubMed ID: 22580292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant glycoprotein production in human cell lines.
    Swiech K; de Freitas MC; Covas DT; Picanço-Castro V
    Methods Mol Biol; 2015; 1258():223-40. PubMed ID: 25447867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein production in moss bioreactors.
    Decker EL; Reski R
    Plant Cell Rep; 2012 Mar; 31(3):453-60. PubMed ID: 21960098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current achievements in the production of complex biopharmaceuticals with moss bioreactors.
    Decker EL; Reski R
    Bioprocess Biosyst Eng; 2008 Jan; 31(1):3-9. PubMed ID: 17701058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical Characterization of Human Anti-Hepatitis B Monoclonal Antibody Produced in the Microalgae Phaeodactylum tricornutum.
    Vanier G; Hempel F; Chan P; Rodamer M; Vaudry D; Maier UG; Lerouge P; Bardor M
    PLoS One; 2015; 10(10):e0139282. PubMed ID: 26437211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant expression systems in the pharmaceutical industry.
    Schmidt FR
    Appl Microbiol Biotechnol; 2004 Sep; 65(4):363-72. PubMed ID: 15480623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriate glycosylation of recombinant proteins for human use: implications of choice of expression system.
    Brooks SA
    Mol Biotechnol; 2004 Nov; 28(3):241-55. PubMed ID: 15542924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant protein production in yeasts.
    Mattanovich D; Branduardi P; Dato L; Gasser B; Sauer M; Porro D
    Methods Mol Biol; 2012; 824():329-58. PubMed ID: 22160907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Targeting for Precision Glyco-Engineering: Production of Biopharmaceuticals Devoid of Plant-Typical Glycosylation in Moss Bioreactors.
    Decker EL; Wiedemann G; Reski R
    Methods Mol Biol; 2015; 1321():213-24. PubMed ID: 26082225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of Recombinant Factor VIII in Human Cell Lines.
    Fantacini DMC; Picanço-Castro V
    Methods Mol Biol; 2018; 1674():63-74. PubMed ID: 28921428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human rhabdomyosarcoma cell line TE671--Towards an innovative production platform for glycosylated biopharmaceuticals.
    Rosenlöcher J; Weilandt C; Sandig G; Reinke SO; Blanchard V; Hinderlich S
    Protein Expr Purif; 2015 Nov; 115():83-94. PubMed ID: 26272370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein secretion systems in microbial and mammalian cells.
    Moir DT; Mao JI
    Bioprocess Technol; 1990; 9():67-94. PubMed ID: 1366891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanizing glycosylation pathways in eukaryotic expression systems.
    Khan AH; Bayat H; Rajabibazl M; Sabri S; Rahimpour A
    World J Microbiol Biotechnol; 2017 Jan; 33(1):4. PubMed ID: 27837408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of Biopharmaceuticals in E. coli: Current Scenario and Future Perspectives.
    Baeshen MN; Al-Hejin AM; Bora RS; Ahmed MM; Ramadan HA; Saini KS; Baeshen NA; Redwan EM
    J Microbiol Biotechnol; 2015 Jul; 25(7):953-62. PubMed ID: 25737124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering mammalian cells in bioprocessing - current achievements and future perspectives.
    Lim Y; Wong NS; Lee YY; Ku SC; Wong DC; Yap MG
    Biotechnol Appl Biochem; 2010 Apr; 55(4):175-89. PubMed ID: 20392202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioreactor systems for the production of biopharmaceuticals from animal cells.
    Warnock JN; Al-Rubeai M
    Biotechnol Appl Biochem; 2006 Jul; 45(Pt 1):1-12. PubMed ID: 16764553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of heterologous proteins in plants: strategies for optimal expression.
    Desai PN; Shrivastava N; Padh H
    Biotechnol Adv; 2010; 28(4):427-35. PubMed ID: 20152894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in Yeast Glycosylation Engineering.
    Hamilton SR; Zha D
    Methods Mol Biol; 2015; 1321():73-90. PubMed ID: 26082216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering the baculovirus genome to produce galactosylated antibodies in lepidopteran cells.
    Juliant S; Lévêque M; Cérutti P; Ozil A; Choblet S; Violet ML; Slomianny MC; Harduin-Lepers A; Cérutti M
    Methods Mol Biol; 2013; 988():59-77. PubMed ID: 23475714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.